aTYR PHARMA (ATYR) Debt Ratio (2014 - 2020)
aTYR PHARMA's (ATYR) quarterly Debt Ratio came in at 0.07 in Q3 2020, down 69.62% on a YoY basis from 0.24 in Q4 2019, and down 29.73% quarter-over-quarter from 0.1 in Q2 2020.
Analysis
aTYR PHARMA (ATYR) Debt Ratio (2014 - 2020) Analysis & Trends
aTYR PHARMA (ATYR) has reported Debt Ratio for 7 consecutive years, with 0.07 the latest figure, recorded in Q3 2020.
- For the quarter ending Q3 2020, Debt Ratio fell 69.62% year-over-year to 0.07; the trailing twelve-month figure through Sep 2020 stood at 0.07 (down 69.62% YoY), and the FY2019 full-year result was 0.24, down 20.56% from the prior year.
- Debt Ratio slipped to 0.07 in Q3 2020 per ATYR's latest filing, from 0.1 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.3 in Q4 2018 and bottomed at 0.03 in Q3 2016.
- Historically, Debt Ratio has averaged 0.18 across 5 years, with a median of 0.22 in 2017.
- The sharpest annual moves came in 2016 and 2017: Debt Ratio plunged 76.35% in 2016, then soared 583.01% in 2017.
- Over 5 years, Debt Ratio stood at 0.12 in 2016, then soared by 86.44% to 0.22 in 2017, then jumped by 37.63% to 0.3 in 2018, then decreased by 20.56% to 0.24 in 2019, then slumped by 69.55% to 0.07 in 2020.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.07, 0.1, and 0.13 for Q3 2020, Q2 2020, and Q1 2020 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 0.66 |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 0.05 |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 0.05 |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 0.25 |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | - |
| 10 | aTYR PHARMA | 35.31 Mn | -22.30 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 0.07 |
| Jun 30, 2020 | 0.10 |
| Mar 31, 2020 | 0.13 |
| Dec 31, 2019 | 0.24 |
| Sep 30, 2019 | 0.24 |
| Jun 30, 2019 | 0.25 |
| Mar 31, 2019 | 0.29 |
| Dec 31, 2018 | 0.30 |
| Sep 30, 2018 | 0.30 |
| Jun 30, 2018 | 0.29 |
| Mar 31, 2018 | 0.25 |
| Dec 31, 2017 | 0.22 |
| Sep 30, 2017 | 0.16 |
| Jun 30, 2017 | 0.24 |
| Mar 31, 2017 | 0.15 |
| Dec 31, 2016 | 0.12 |
| Sep 30, 2016 | 0.03 |
| Jun 30, 2016 | 0.03 |
| Mar 31, 2016 | 0.04 |
| Dec 31, 2015 | 0.04 |